Accessibility, Cost, and Quality of an Online Regular Follow-Up Visit Service at an Internet Hospital in China: Mixed Methods Study.

Accessibility, Cost, and Quality of an Online Regular Follow-Up Visit Service at an Internet Hospital in China: Mixed Methods Study.

Publication date: Oct 21, 2024

Telemedicine provides remote health care services to overcome constraints of time and space in accessing medical care. Similarly, internet hospitals in China support and provide remote health care services. Due to the COVID-19 pandemic, there has been a proliferation of internet hospitals. Many new services, including online consultations and regular online follow-up visit services, can now be accessed via internet hospitals in China. However, the accessibility, cost, and quality advantages of regular online follow-up visit services remain unclear. This study aimed to evaluate the accessibility, costs, and quality of an online regular follow-up visit service provided by an internet hospital in China. By analyzing the accessibility, costs, and quality of this service from the supply and demand sides, we can summarize the practical and theoretical experiences. A mixed methods study was conducted using clinical records from 18,473 patients receiving 39,239 online regular follow-up visit services at an internet hospital in 2021, as well as interviews with 7 physicians, 2 head nurses, and 3 administrative staff members. The quantitative analysis examined patient demographics, diagnoses, prescriptions, geographic distribution, physician characteristics, accessibility (travel time and costs), and service hours. The qualitative analysis elucidated physician perspectives on ensuring the quality of online health care. Patients were predominantly middle-aged men with chronic diseases like viral hepatitis who were located near the hospital. The vast majority were from Guangdong province where the hospital is based, especially concentrated in Guangzhou city. The online regular follow-up visit service reduced travel time by 1 hour to 9 hours and costs by yen6 to yen991 (US $0. 86-$141. 32) depending on proximity, with greater savings for patients farther from the hospital. Consultation times were roughly equivalent between online and in-person visits. Physicians provided most online services during lunch breaks (12 PM to 2 PM) or after work hours (7 PM to 11 PM), indicating increased workload. The top departments providing online regular follow-up visit services were Infectious Diseases, Rheumatology, and Dermatology. The most commonly prescribed medications aligned with the prevalent chronic diagnoses. To ensure quality, physicians conducted initial in-person consultations to fully evaluate patients before allowing online regular follow-up visits, during which they communicated with patients to assess conditions and determine if in-person care was warranted. They also periodically reminded patients to come in person for more comprehensive evaluations. However, they acknowledged online visits cannot fully replace face-to-face care. Telemedicine services such as online regular follow-up visit services provided by internet hospitals must strictly adhere to fundamental medical principles of diagnosis, prescription, and treatment. For patients with chronic diseases, online regular follow-up visit services improve accessibility and reduce cost but cannot fully replace in-person evaluations. Physicians leverage various strategies to ensure the quality of online care.

Open Access PDF

Concepts Keywords
China accessibility
Lunch Adolescent
Nurses Adult
Rheumatology Aged
Child
Child, Preschool
China
cost
COVID-19
Female
Health Services Accessibility
Humans
Infant
Internet
internet hospital
Male
medical service
Middle Aged
Pandemics
quality
regular follow-up
SARS-CoV-2
Telemedicine
Young Adult

Semantics

Type Source Name
disease IDO quality
disease MESH COVID-19 pandemic
drug DRUGBANK Etoperidone
disease MESH chronic diseases
disease MESH hepatitis
disease MESH Infectious Diseases
drug DRUGBANK Methylphenidate
drug DRUGBANK Medroxyprogesterone acetate
disease IDO symptom
drug DRUGBANK Alpha-1-proteinase inhibitor
disease IDO process
drug DRUGBANK Methionine
disease MESH liver cirrhosis
disease MESH tumor
disease MESH arthritis
disease MESH syndrome
drug DRUGBANK Entecavir
disease MESH chronic hepatitis
disease MESH liver diseases
disease MESH complications
drug DRUGBANK Carbonate ion
drug DRUGBANK Glycyrrhizic acid
drug DRUGBANK Sulfate ion
disease IDO history
disease MESH morbidity
disease MESH IgA nephropathy
disease MESH chest pain
disease IDO blood
disease MESH missing diagnosis
disease MESH Stroke
drug DRUGBANK Guanosine
drug DRUGBANK Coenzyme M
disease IDO site
disease IDO country
drug DRUGBANK Carboxyamidotriazole
drug DRUGBANK Methylergometrine
pathway REACTOME Reproduction
disease MESH Health Services Accessibility

Original Article

(Visited 3 times, 1 visits today)